 | • レポートコード：QY20ST-06721 • 出版社/出版日：QYResearch / 2020年9月15日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥560,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥840,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界のヘモフィルスインフルエンザB型ワクチン市場について種類別（液体一価HIB、液体配合HIB、凍結乾燥一価HIB、凍結乾燥配合HIB）、用途別（病院、研究機関、製薬・バイオテクノロジー企業、学術機関、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・ヘモフィルスインフルエンザB型ワクチン市場の概要 ・世界の主要地域別ヘモフィルスインフルエンザB型ワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のヘモフィルスインフルエンザB型ワクチン市場規模2015-2026：種類別（液体一価HIB、液体配合HIB、凍結乾燥一価HIB、凍結乾燥配合HIB） ・世界のヘモフィルスインフルエンザB型ワクチン市場規模2015-2026：用途別（病院、研究機関、製薬・バイオテクノロジー企業、学術機関、その他） ・ヘモフィルスインフルエンザB型ワクチンの北米市場規模2015-2020 ・ヘモフィルスインフルエンザB型ワクチンのヨーロッパ市場規模2015-2020 ・ヘモフィルスインフルエンザB型ワクチンの中国市場規模2015-2020 ・ヘモフィルスインフルエンザB型ワクチンの日本市場規模2015-2020 ・ヘモフィルスインフルエンザB型ワクチンの東南アジア市場規模2015-2020 ・ヘモフィルスインフルエンザB型ワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・ヘモフィルスインフルエンザB型ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ヘモフィルスインフルエンザB型ワクチンの市場動向・機会・課題 ・調査の結論 |
Haemophilus influenzae b is the leading cause of death and morbidity in children, and its six entities are meningitis, bacterial pneumonia, epiglottitis, septicaemia, cellulitis and bone and joint infections.HIB disease is the cause of about 90 percent of child deaths each year.HIB vaccines are effective and safe for infants because they contain polyribonitol phosphate that binds to proteins in response to meningitis and pneumonia in children.
Market Analysis and Insights: Global Haemophilus Influenzae Type B Vaccine Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Haemophilus Influenzae Type B Vaccine market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Haemophilus Influenzae Type B Vaccine industry.
Based on our recent survey, we have several different scenarios about the Haemophilus Influenzae Type B Vaccine YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Haemophilus Influenzae Type B Vaccine will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Haemophilus Influenzae Type B Vaccine Scope and Market Size
The global Haemophilus Influenzae Type B Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Haemophilus Influenzae Type B Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Haemophilus Influenzae Type B Vaccine market is segmented into
Liquid Monovalent HIB
Liquid Combination HIB
Lyophilized Monovalent HIB
Lyophilized Combination HIB
Segment by Application, the Haemophilus Influenzae Type B Vaccine market is segmented into
Hospital
Research Institutions
Pharmaceutical and Biotechnology Companies
Academic Institutions
Other
The Haemophilus Influenzae Type B Vaccine market is analysed and market size information is provided by regions (countries). Segment by Application, the Haemophilus Influenzae Type B Vaccine market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Haemophilus Influenzae Type B Vaccine Market Share Analysis
Haemophilus Influenzae Type B Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Haemophilus Influenzae Type B Vaccine business, the date to enter into the Haemophilus Influenzae Type B Vaccine market, Haemophilus Influenzae Type B Vaccine product introduction, recent developments, etc.
The major vendors covered:
Novartis
Merck
Sanofi
GlaxoSmithKline
Takeda Pharmaceuticals Company
Walvax Biotechnology
Lanzhou Institute of Biologica
Immunize BC
1 Haemophilus Influenzae Type B Vaccine Market Overview
1.1 Haemophilus Influenzae Type B Vaccine Product Scope
1.2 Haemophilus Influenzae Type B Vaccine Segment by Type
1.2.1 Global Haemophilus Influenzae Type B Vaccine Sales by Type (2020-2026)
1.2.2 Liquid Monovalent HIB
1.2.3 Liquid Combination HIB
1.2.4 Lyophilized Monovalent HIB
1.2.5 Lyophilized Combination HIB
1.3 Haemophilus Influenzae Type B Vaccine Segment by Application
1.3.1 Global Haemophilus Influenzae Type B Vaccine Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Research Institutions
1.3.4 Pharmaceutical and Biotechnology Companies
1.3.5 Academic Institutions
1.3.6 Other
1.4 Haemophilus Influenzae Type B Vaccine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2026)
1.4.2 Global Haemophilus Influenzae Type B Vaccine Revenue and Growth Rate (2015-2026)
1.4.3 Global Haemophilus Influenzae Type B Vaccine Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Haemophilus Influenzae Type B Vaccine Industry Impact
1.5.1 How the Covid-19 is Affecting the Haemophilus Influenzae Type B Vaccine Industry
1.5.1.1 Haemophilus Influenzae Type B Vaccine Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Haemophilus Influenzae Type B Vaccine Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Haemophilus Influenzae Type B Vaccine Players to Combat Covid-19 Impact
2 Haemophilus Influenzae Type B Vaccine Estimate and Forecast by Region
2.1 Global Haemophilus Influenzae Type B Vaccine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Haemophilus Influenzae Type B Vaccine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Region (2015-2020)
2.2.2 Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region (2015-2020)
2.3 Global Haemophilus Influenzae Type B Vaccine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Haemophilus Influenzae Type B Vaccine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Haemophilus Influenzae Type B Vaccine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Haemophilus Influenzae Type B Vaccine Estimates and Projections (2015-2026)
2.4.2 Europe Haemophilus Influenzae Type B Vaccine Estimates and Projections (2015-2026)
2.4.3 China Haemophilus Influenzae Type B Vaccine Estimates and Projections (2015-2026)
2.4.4 Japan Haemophilus Influenzae Type B Vaccine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Haemophilus Influenzae Type B Vaccine Estimates and Projections (2015-2026)
2.4.6 India Haemophilus Influenzae Type B Vaccine Estimates and Projections (2015-2026)
3 Global Haemophilus Influenzae Type B Vaccine Competition Landscape by Players
3.1 Global Top Haemophilus Influenzae Type B Vaccine Players by Sales (2015-2020)
3.2 Global Top Haemophilus Influenzae Type B Vaccine Players by Revenue (2015-2020)
3.3 Global Haemophilus Influenzae Type B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Haemophilus Influenzae Type B Vaccine as of 2019)
3.4 Global Haemophilus Influenzae Type B Vaccine Average Price by Company (2015-2020)
3.5 Manufacturers Haemophilus Influenzae Type B Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Haemophilus Influenzae Type B Vaccine Players (Opinion Leaders)
4 Global Haemophilus Influenzae Type B Vaccine Market Size by Type
4.1 Global Haemophilus Influenzae Type B Vaccine Historic Market Review by Type (2015-2020)
4.1.1 Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2015-2020)
4.1.2 Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2015-2020)
4.1.3 Global Haemophilus Influenzae Type B Vaccine Price by Type (2014-2020)
4.2 Global Haemophilus Influenzae Type B Vaccine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Haemophilus Influenzae Type B Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Haemophilus Influenzae Type B Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Global Haemophilus Influenzae Type B Vaccine Price Forecast by Type (2021-2026)
5 Global Haemophilus Influenzae Type B Vaccine Market Size by Application
5.1 Global Haemophilus Influenzae Type B Vaccine Historic Market Review by Application (2015-2020)
5.1.1 Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2015-2020)
5.1.2 Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application (2015-2020)
5.1.3 Global Haemophilus Influenzae Type B Vaccine Price by Application (2015-2020)
5.2 Global Haemophilus Influenzae Type B Vaccine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Haemophilus Influenzae Type B Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Haemophilus Influenzae Type B Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Haemophilus Influenzae Type B Vaccine Price Forecast by Application (2021-2026)
3 North America Haemophilus Influenzae Type B Vaccine Market Facts & Figures
3.2 North America Haemophilus Influenzae Type B Vaccine Sales Market Share by Company (2015-2020)
3.3 North America Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2015-2020)
3.4 North America Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2015-2020)
4 Europe Haemophilus Influenzae Type B Vaccine Market Facts & Figures
4.2 Europe Haemophilus Influenzae Type B Vaccine Sales Market Share by Company (2015-2020)
4.3 Europe Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2015-2020)
4.4 Europe Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2015-2020)
5 China Haemophilus Influenzae Type B Vaccine Market Facts & Figures
5.2 China Haemophilus Influenzae Type B Vaccine Sales Market Share by Company (2015-2020)
5.3 China Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2015-2020)
5.4 China Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2015-2020)
6 Japan Haemophilus Influenzae Type B Vaccine Market Facts & Figures
6.2 Japan Haemophilus Influenzae Type B Vaccine Sales Market Share by Company (2015-2020)
6.3 Japan Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2015-2020)
6.4 Japan Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2015-2020)
7 Southeast Asia Haemophilus Influenzae Type B Vaccine Market Facts & Figures
7.2 Southeast Asia Haemophilus Influenzae Type B Vaccine Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2015-2020)
8 India Haemophilus Influenzae Type B Vaccine Market Facts & Figures
8.2 India Haemophilus Influenzae Type B Vaccine Sales Market Share by Company (2015-2020)
8.3 India Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2015-2020)
8.4 India Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Haemophilus Influenzae Type B Vaccine Business
12.1 Novartis
12.1.1 Novartis Haemophilus Influenzae Type B Vaccine Corporation Information
12.1.2 Novartis Haemophilus Influenzae Type B Vaccine Business Overview and Total Revenue
12.1.3 Novartis Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Novartis Haemophilus Influenzae Type B Vaccine Products Offered
12.1.5 Novartis Recent Development
12.2 Merck
12.2.1 Merck Haemophilus Influenzae Type B Vaccine Corporation Information
12.2.2 Merck Haemophilus Influenzae Type B Vaccine Business Overview and Total Revenue
12.2.3 Merck Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Merck Haemophilus Influenzae Type B Vaccine Products Offered
12.2.5 Merck Recent Development
12.3 Sanofi
12.3.1 Sanofi Haemophilus Influenzae Type B Vaccine Corporation Information
12.3.2 Sanofi Haemophilus Influenzae Type B Vaccine Business Overview and Total Revenue
12.3.3 Sanofi Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Sanofi Haemophilus Influenzae Type B Vaccine Products Offered
12.3.5 Sanofi Recent Development
12.4 GlaxoSmithKline
12.4.1 GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Corporation Information
12.4.2 GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Business Overview and Total Revenue
12.4.3 GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Products Offered
12.4.5 GlaxoSmithKline Recent Development
12.5 Takeda Pharmaceuticals Company
12.5.1 Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Corporation Information
12.5.2 Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Business Overview and Total Revenue
12.5.3 Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Products Offered
12.5.5 Takeda Pharmaceuticals Company Recent Development
12.6 Walvax Biotechnology
12.6.1 Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Corporation Information
12.6.2 Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Business Overview and Total Revenue
12.6.3 Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Products Offered
12.6.5 Walvax Biotechnology Recent Development
12.7 Lanzhou Institute of Biologica
12.7.1 Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Corporation Information
12.7.2 Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Business Overview and Total Revenue
12.7.3 Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Products Offered
12.7.5 Lanzhou Institute of Biologica Recent Development
12.8 Immunize BC
12.8.1 Immunize BC Haemophilus Influenzae Type B Vaccine Corporation Information
12.8.2 Immunize BC Haemophilus Influenzae Type B Vaccine Business Overview and Total Revenue
12.8.3 Immunize BC Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Immunize BC Haemophilus Influenzae Type B Vaccine Products Offered
12.8.5 Immunize BC Recent Development
13 Haemophilus Influenzae Type B Vaccine Manufacturing Cost Analysis
13.1 Haemophilus Influenzae Type B Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Haemophilus Influenzae Type B Vaccine
13.4 Haemophilus Influenzae Type B Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Haemophilus Influenzae Type B Vaccine Distributors List
14.3 Haemophilus Influenzae Type B Vaccine Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Haemophilus Influenzae Type B Vaccine Sales (M Doses) Growth Rate by Type (2020-2026)
Table 2. Global Haemophilus Influenzae Type B Vaccine Sales (M Doses) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Haemophilus Influenzae Type B Vaccine Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Haemophilus Influenzae Type B Vaccine Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Haemophilus Influenzae Type B Vaccine Players to Combat Covid-19 Impact
Table 8. Global Market Haemophilus Influenzae Type B Vaccine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Haemophilus Influenzae Type B Vaccine Sales (M Doses) by Region (2015-2020)
Table 10. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Region (2015-2020)
Table 11. Global Haemophilus Influenzae Type B Vaccine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Haemophilus Influenzae Type B Vaccine Revenue Share by Region (2015-2020)
Table 13. Global Haemophilus Influenzae Type B Vaccine Sales (M Doses) Forecast by Region (2021-2026)
Table 14. Global Haemophilus Influenzae Type B Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Haemophilus Influenzae Type B Vaccine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Haemophilus Influenzae Type B Vaccine Revenue Share Forecast by Region (2021-2026)
Table 17. Global Haemophilus Influenzae Type B Vaccine (M Doses) of Key Companies (2015-2020)
Table 18. Global Haemophilus Influenzae Type B Vaccine Sales Share by Company (2015-2020)
Table 19. Global Haemophilus Influenzae Type B Vaccine Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Haemophilus Influenzae Type B Vaccine Revenue Share by Company (2015-2020)
Table 21. Global Haemophilus Influenzae Type B Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Haemophilus Influenzae Type B Vaccine as of 2019)
Table 22. Global Haemophilus Influenzae Type B Vaccine Average Price (USD/Dose) of Key Company (2015-2020)
Table 23. Manufacturers Haemophilus Influenzae Type B Vaccine Manufacturing Sites and Area Served
Table 24. Manufacturers Haemophilus Influenzae Type B Vaccine Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Haemophilus Influenzae Type B Vaccine Players
Table 27. Global Haemophilus Influenzae Type B Vaccine Sales (M Doses) by Type (2015-2020)
Table 28. Global Haemophilus Influenzae Type B Vaccine Sales Share by Type (2015-2020)
Table 29. Global Haemophilus Influenzae Type B Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Haemophilus Influenzae Type B Vaccine Price (M Doses) by Type (2015-2020)
Table 31. Global Haemophilus Influenzae Type B Vaccine Sales Share by Type (2021-2026)
Table 32. Global Haemophilus Influenzae Type B Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Haemophilus Influenzae Type B Vaccine Revenue Share by Type (2021-2026)
Table 34. Global Haemophilus Influenzae Type B Vaccine Price (M Doses) by Type (2021-2026)
Table 35. Global Haemophilus Influenzae Type B Vaccine Sales (M Doses) by Application (2015-2020)
Table 36. Global Haemophilus Influenzae Type B Vaccine Sales Share by Application (2015-2020)
Table 37. Global Haemophilus Influenzae Type B Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Haemophilus Influenzae Type B Vaccine Price (M Doses) by Application (2015-2020)
Table 39. Global Haemophilus Influenzae Type B Vaccine Sales (M Doses) by Application (2021-2026)
Table 40. Global Haemophilus Influenzae Type B Vaccine Sales Share by Application (2021-2026)
Table 41. Global Haemophilus Influenzae Type B Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Haemophilus Influenzae Type B Vaccine Revenue Share by Application (2021-2026)
Table 43. Global Haemophilus Influenzae Type B Vaccine Price (M Doses) by Application (2021-2026)
Table 44. United States Haemophilus Influenzae Type B Vaccine Sales (M Doses) by Company (2015-2020)
Table 45. United States Haemophilus Influenzae Type B Vaccine Sales Market Share by Company (2015-2020)
Table 46. United States Haemophilus Influenzae Type B Vaccine Sales (M Doses) by Type (2015-2020)
Table 47. United States Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2015-2020)
Table 48. United States Haemophilus Influenzae Type B Vaccine Sales (M Doses) by Application (2015-2020)
Table 49. United States Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2015-2020)
Table 50. Europe Haemophilus Influenzae Type B Vaccine Sales (M Doses) by Company (2015-2020)
Table 51. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share by Company (2015-2020)
Table 52. Europe Haemophilus Influenzae Type B Vaccine Sales (M Doses) by Type (2015-2020)
Table 53. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2015-2020)
Table 54. Europe Haemophilus Influenzae Type B Vaccine Sales (M Doses) by Application (2015-2020)
Table 55. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2015-2020)
Table 56. China Haemophilus Influenzae Type B Vaccine Sales (M Doses) by Company (2015-2020)
Table 57. China Haemophilus Influenzae Type B Vaccine Sales Market Share by Company (2015-2020)
Table 58. China Haemophilus Influenzae Type B Vaccine Sales (M Doses) by Type (2015-2020)
Table 59. China Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2015-2020)
Table 60. China Haemophilus Influenzae Type B Vaccine Sales (M Doses) by Application (2015-2020)
Table 61. China Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2015-2020)
Table 62. Japan Haemophilus Influenzae Type B Vaccine Sales (M Doses) by Company (2015-2020)
Table 63. Japan Haemophilus Influenzae Type B Vaccine Sales Market Share by Company (2015-2020)
Table 64. Japan Haemophilus Influenzae Type B Vaccine Sales (M Doses) by Type (2015-2020)
Table 65. Japan Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2015-2020)
Table 66. Japan Haemophilus Influenzae Type B Vaccine Sales (M Doses) by Application (2015-2020)
Table 67. Japan Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Haemophilus Influenzae Type B Vaccine Sales (M Doses) by Company (2015-2020)
Table 69. Southeast Asia Haemophilus Influenzae Type B Vaccine Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Haemophilus Influenzae Type B Vaccine Sales (M Doses) by Type (2015-2020)
Table 71. Southeast Asia Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Haemophilus Influenzae Type B Vaccine Sales (M Doses) by Type (2015-2020)
Table 73. Southeast Asia Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2015-2020)
Table 74. India Haemophilus Influenzae Type B Vaccine Sales (M Doses) by Company (2015-2020)
Table 75. India Haemophilus Influenzae Type B Vaccine Sales Market Share by Company (2015-2020)
Table 76. India Haemophilus Influenzae Type B Vaccine Sales (M Doses) by Type (2015-2020)
Table 77. India Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2015-2020)
Table 78. India Haemophilus Influenzae Type B Vaccine Sales (M Doses) by Application (2015-2020)
Table 79. India Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2015-2020)
Table 80. Novartis Corporation Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 83. Novartis Haemophilus Influenzae Type B Vaccine Product
Table 84. Novartis Recent Development
Table 85. Merck Corporation Information
Table 86. Merck Description and Business Overview
Table 87. Merck Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 88. Merck Haemophilus Influenzae Type B Vaccine Product
Table 89. Merck Recent Development
Table 90. Sanofi Corporation Information
Table 91. Sanofi Description and Business Overview
Table 92. Sanofi Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 93. Sanofi Haemophilus Influenzae Type B Vaccine Product
Table 94. Sanofi Recent Development
Table 95. GlaxoSmithKline Corporation Information
Table 96. GlaxoSmithKline Description and Business Overview
Table 97. GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 98. GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Product
Table 99. GlaxoSmithKline Recent Development
Table 100. Takeda Pharmaceuticals Company Corporation Information
Table 101. Takeda Pharmaceuticals Company Description and Business Overview
Table 102. Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 103. Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Product
Table 104. Takeda Pharmaceuticals Company Recent Development
Table 105. Walvax Biotechnology Corporation Information
Table 106. Walvax Biotechnology Description and Business Overview
Table 107. Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 108. Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Product
Table 109. Walvax Biotechnology Recent Development
Table 110. Lanzhou Institute of Biologica Corporation Information
Table 111. Lanzhou Institute of Biologica Description and Business Overview
Table 112. Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 113. Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Product
Table 114. Lanzhou Institute of Biologica Recent Development
Table . Immunize BC Corporation Information
Table . Immunize BC Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table . Immunize BC Description and Business Overview
Table . Immunize BC Haemophilus Influenzae Type B Vaccine Product
Table . Immunize BC Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Haemophilus Influenzae Type B Vaccine Distributors List
Table 123. Haemophilus Influenzae Type B Vaccine Customers List
Table 124. Market Key Trends
Table 125. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 126. Key Challenges
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Haemophilus Influenzae Type B Vaccine Product Picture
Figure 2. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Haemophilus Influenzae Type B Vaccine Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Research Institutions Examples
Figure 8. Pharmaceutical and Biotechnology Companies Examples
Figure 9. Academic Institutions Examples
Figure 10. Other Examples
Figure 11. Global Haemophilus Influenzae Type B Vaccine Sales (M Doses) Growth Rate (2015-2026)
Figure 12. Global Haemophilus Influenzae Type B Vaccine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 13. Global Haemophilus Influenzae Type B Vaccine Price Trends Growth Rate (2015-2026) (USD/Dose)
Figure 14. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region: 2015 VS 2020
Figure 15. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region: 2021 VS 2026
Figure 16. United States Haemophilus Influenzae Type B Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. United States Haemophilus Influenzae Type B Vaccine Sales (M Doses) Growth Rate (2015-2026)
Figure 18. Europe Haemophilus Influenzae Type B Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. Europe Haemophilus Influenzae Type B Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 20. China Haemophilus Influenzae Type B Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. China Haemophilus Influenzae Type B Vaccine Sales (Million USD) and Growth Rate (2015-2026)
Figure 22. Japan Haemophilus Influenzae Type B Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Japan Haemophilus Influenzae Type B Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Haemophilus Influenzae Type B Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. Southeast Asia Haemophilus Influenzae Type B Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 26. India Haemophilus Influenzae Type B Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 27. India Haemophilus Influenzae Type B Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 28. Global 5 Largest Haemophilus Influenzae Type B Vaccine Players Market Share by Revenue in Haemophilus Influenzae Type B Vaccine 2015 & 2019
Figure 29. Haemophilus Influenzae Type B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 30. Global Haemophilus Influenzae Type B Vaccine Revenue Share by Type (2015-2020)
Figure 31. Global Haemophilus Influenzae Type B Vaccine Revenue Growth Rate by Type in 2015 & 2019
Figure 32. Global Haemophilus Influenzae Type B Vaccine Revenue Share by Application (2015-2020)
Figure 33. Global Haemophilus Influenzae Type B Vaccine Revenue Growth Rate by Application in 2015 & 2019
Figure 34. United States Haemophilus Influenzae Type B Vaccine Sales Market Share by Type in 2019
Figure 35. United States Haemophilus Influenzae Type B Vaccine Sales Market Share by Type in 2019
Figure 36. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share by Company in 2019
Figure 37. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share by Type in 2019
Figure 38. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share by Application in 2019
Figure 39. China Haemophilus Influenzae Type B Vaccine Sales Market Share by Company in 2019
Figure 40. China Haemophilus Influenzae Type B Vaccine Sales Market Share by Type in 2019
Figure 41. China Haemophilus Influenzae Type B Vaccine Sales Market Share by Application in 2019
Figure 42. Japan Haemophilus Influenzae Type B Vaccine Sales Market Share by Company in 2019
Figure 43. Japan Haemophilus Influenzae Type B Vaccine Sales Market Share by Type in 2019
Figure 44. Japan Haemophilus Influenzae Type B Vaccine Sales Market Share by Application in 2019
Figure 45. Southeast Asia Haemophilus Influenzae Type B Vaccine Sales Market Share by Company in 2019
Figure 46. Southeast Asia Haemophilus Influenzae Type B Vaccine Sales Market Share by Type in 2019
Figure 47. Southeast Asia Haemophilus Influenzae Type B Vaccine Sales Market Share by Application in 2019
Figure 48. India Haemophilus Influenzae Type B Vaccine Sales Market Share by Company in 2019
Figure 49. India Haemophilus Influenzae Type B Vaccine Sales Market Share by Type in 2019
Figure 50. India Haemophilus Influenzae Type B Vaccine Sales Market Share by Application in 2019
Figure 51. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Takeda Pharmaceuticals Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Walvax Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Lanzhou Institute of Biologica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Immunize BC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Key Raw Materials Price Trend
Figure 60. Manufacturing Cost Structure of Haemophilus Influenzae Type B Vaccine
Figure 61. Manufacturing Process Analysis of Haemophilus Influenzae Type B Vaccine
Figure 62. Haemophilus Influenzae Type B Vaccine Industrial Chain Analysis
Figure 63. Channels of Distribution
Figure 64. Distributors Profiles
Figure 65. Porter's Five Forces Analysis
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
帯状疱疹ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Shingles Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Shingles Vaccine market repo…- 水痘弱毒生ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Varicella Attenuated Live Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain o…
- 水痘生ワクチンの世界市場レポート2020 A recently published report by QY Research titled Global Varicella Live Vaccine Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accu…
- 水痘生ワクチンの世界市場レポート2020 A recently published report by QY Research titled Global Varicella Live Vaccine Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accu…
- 遺伝ワクチンの世界市場レポート2020 A recently published report by QY Research titled Global Genetic Vaccine Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate da…